{
    "organizations": [],
    "uuid": "c475f4f7a3cb7b1374eda0fac1de4474ff22a5df",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-inmed-pharmaceuticals-reports-q3-l/brief-inmed-pharmaceuticals-reports-q3-loss-per-share-of-c0-01-idUSASC0A1R8",
    "ord_in_thread": 0,
    "title": "BRIEF-Inmed Pharmaceuticals Reports Q3 Loss Per Share Of C$0.01",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - InMed Pharmaceuticals Inc:\n* INMED REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* Q3 LOSS PER SHARE C$0.01 * INMED PHARMACEUTICALS - AT MARCH 31, 2018, COâ€™S CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $13.88 MILLION, VERSUS $6.71 MILLION AT JUNE 30, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T19:35:00.000+03:00",
    "crawled": "2018-05-12T17:24:52.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "inmed",
        "pharmaceutical",
        "inc",
        "inmed",
        "report",
        "third",
        "quarter",
        "fiscal",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q3",
        "loss",
        "per",
        "share",
        "c",
        "inmed",
        "pharmaceutical",
        "march",
        "co",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "versus",
        "million",
        "june",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}